Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zelei Dai

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|November 29, 2023
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.govZelei Dai, Nian Li, Jun Wang, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|September 18, 2025
[Interpretation and Examples: Key Updates in SPIRIT 2025 Statement]Zelei Dai, Renjie Zhao, Kefan Li, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|September 18, 2025
[Interpretation and Examples: Key Updates in CONSORT 2025]Zelei Dai, Renjie Zhao, Kefan Li, et al.
Journal of Medical Internet Research|December 21, 2023
Correction: Guidelines, Consensus Statements, and Standards for the Use of Artificial Intelligence in Medicine: Systematic ReviewYing Wang, Nian Li, Lingmin Chen, et al.
Journal of Medical Internet Research|November 22, 2023
Guidelines, Consensus Statements, and Standards for the Use of Artificial Intelligence in Medicine: Systematic ReviewYing Wang, Nian Li, Lingmin Chen, et al.
Frontiers in Oncology|July 26, 2023
The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancerYuanyuan Zeng, Jun Wang, Xiaorong Zhong, et al.
The Oncologist|July 7, 2026
Target trial emulation studies in oncology: a comprehensive analysisChenfeng Tan, Zelei Dai, Renjie Zhao, et al.
BMC Complementary Medicine and Therapies|September 16, 2023
Factors influencing the quality of acupuncture clinical trials: a qualitative interview of stakeholdersYing He, Nian Li, Qin Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 1, 2022
Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence MapYing Wang, Zelei Dai, Qin Wang, et al.
Cancer Medicine|February 3, 2023
The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancerTian Yang, Xiaorong Zhong, Jun Wang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|November 29, 2023
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.govZelei Dai, Nian Li, Jun Wang, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|September 18, 2025
[Interpretation and Examples: Key Updates in SPIRIT 2025 Statement]Zelei Dai, Renjie Zhao, Kefan Li, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|September 18, 2025
[Interpretation and Examples: Key Updates in CONSORT 2025]Zelei Dai, Renjie Zhao, Kefan Li, et al.
Journal of Medical Internet Research|December 21, 2023
Correction: Guidelines, Consensus Statements, and Standards for the Use of Artificial Intelligence in Medicine: Systematic ReviewYing Wang, Nian Li, Lingmin Chen, et al.
Journal of Medical Internet Research|November 22, 2023
Guidelines, Consensus Statements, and Standards for the Use of Artificial Intelligence in Medicine: Systematic ReviewYing Wang, Nian Li, Lingmin Chen, et al.
Frontiers in Oncology|July 26, 2023
The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancerYuanyuan Zeng, Jun Wang, Xiaorong Zhong, et al.
The Oncologist|July 7, 2026
Target trial emulation studies in oncology: a comprehensive analysisChenfeng Tan, Zelei Dai, Renjie Zhao, et al.
BMC Complementary Medicine and Therapies|September 16, 2023
Factors influencing the quality of acupuncture clinical trials: a qualitative interview of stakeholdersYing He, Nian Li, Qin Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 1, 2022
Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence MapYing Wang, Zelei Dai, Qin Wang, et al.
Cancer Medicine|February 3, 2023
The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancerTian Yang, Xiaorong Zhong, Jun Wang, et al.
Pageof 2